Lixte Biotechnology Holdings Inc. held annual shareholder meeting
I'm PortAI, I can summarize articles.
Lixte Biotechnology Holdings Inc. held its Annual Meeting on December 8, 2025. Shareholders elected Geordan Pursglove, Jason Sawyer, Dr. Michael Holloway, Lourdes Felix, and Guy Primus to the board of directors. They also ratified Weinberg & Company, P.A. as the independent accounting firm for 2025 and approved an amendment to the 2020 Plan, increasing common stock shares from 2.75 million to 3.5 million.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments